Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

doi:10.3748/wjg.14.1521

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2976)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

331

HTML

2320

Figures (1-4)

163

Tables (1-2)

162

Sum=2976

Mar 14, 2008 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 14, 2008; 14(10): 1521-1527
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1521

Full Size Figure Download Figure

Figure 2 Variation of mRNA expression for FoxP3 in CD4+ T cells in matched samples from 6 patients treated by GMA-apheresis: Quantitative PCR was performed as described in methods; Results are expressed as FoxP3 expression relative to GUS expression per cent.

Citation: Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1521.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1521